Pain Treatment Centers

Stephen T. Pyles, MD-Spinal Stimulation Therapy for Pain Management

352-861-4600
2300 South Pine Ave. • Ocala, FL 34471
  • Home
  • Services
  • About Dr. Pyles
  • Blog
  • News
  • Testimonials
    • Television Commercials
  • Links

Blog

GAO Report Claims DEA to Blame for Many Drug Shortages

Posted on 03.20.15 |

Ken Terry | March 17, 2015 www.medscape.com

The US Drug Enforcement Agency (DEA) and the US Food and Drug Administration (FDA) should work together more closely to prevent shortages of prescription medications containing controlled substances, said a blistering new report from the General Accountability Office (GAO). The DEA should also improve its process for authorizing quotas of the controlled substances used in these drugs, the report recommends.
Shortages of prescription drugs containing controlled substances have increased in recent years, the report notes. Of the 168 shortages from January 2001 to June 2013, nearly 70% began after 2007. Shortages lasted nearly a year on average. Many shortages involved generic pain relievers and drugs with only one manufacturer.
Of the 168 shortages, 87 were identified as critical. More than half of those drug shortages involved analgesics. There were also shortages among this group of antianxiety drugs, sedative hypnotics, and stimulants, among others.
According to the FDA and organizations representing patients and providers, the GAO said, these shortages can lead to less effective care, no treatment, and/or medication errors. Providers spend time and resources mitigating the effects of drug shortages instead of taking care of patients.
One cause of these shortages, pharmaceutical companies charge, is the amount of time it takes the DEA to approve controlled substance quotas. The DEA has created these quotas for each class of controlled substances and for each manufacturer of drugs containing these agents to prevent their diversion to illegal uses.
According to the GAO report, the DEA did not respond to manufacturers’ quota applications within the time frames required by the agency’s own regulations for any year from 2001 to 2014. Even after the DEA implemented an electronic system to streamline this process in 2011, the report said, it took an average of 58 days to respond to quota applications in 2011 and 2012.
The DEA denied that its lack of adherence to its own quota application processing time frames has caused shortages of drugs, the report said. But the FDA data on the causes of 40 shortages of drugs containing controlled substances from January 2010 to 2013 showed that seven of these shortages “were caused by problems related to quota,” the report notes. Other shortages resulted from factors such as manufacturing delays, capacity issues, and product quality issues.
The GAO made several recommendations to improve the DEA’s management of the quota application process and to avoid future drug shortages. Among other things, the GAO advised the DEA and the FDA to update their existing memorandum of understanding, which has not been revised since the 1970s.
There is bipartisan interest on Capitol Hill in combatting the increasingly serious problem of medical drug shortages. Sen. Charles Grassley (R­IA) and Sen. Sheldon Whitehouse (D­RI) commissioned the GAO report in 2012, and next month, Grassley and Sen. Dianne Feinstein (D­CA), the leaders of the Caucus on International Narcotics Control, are scheduled to hold a hearing on the report’s findings.
Negative Effect on Healthcare
Leaders of medical societies whose members are especially dependent on prescribing drugs containing controlled substances told Medscape Medical News that shortages of these medications have grown steadily worse in recent years.
“We are seeing regular and increasing shortages of these drugs,” said Beverly Philip, MD, vice president of scientific affairs for the American Society of Anesthesiologists. She cited a 2011 society survey of anesthesiologists showing that 90% of respondents reported they were currently experiencing a shortage of least one anesthesia drug, and that 98% had encountered a shortage within the past year.
As a result of these shortages, 49% of patients experienced a less optimal outcome (eg, postoperative nausea and vomiting), the survey found, and the same percentage of patients had longer operating room or recovery times than they otherwise would have had.
“When one of these drugs go on shortage, we have to look for alternatives,” Dr Philip noted. “That’s not easy, because there are drugs in the same class, but they’re just not the same. They have different strengths, different doses, they last different amounts of time. So we don’t have interchangeable drugs.”
The current shortage of midazolam, a drug commonly used to relax patients before they have surgery, shows how this problem affects patients, Dr Philip said. There are other drugs in the same category but they are much longer acting, which is not good for the patient, she noted.
Emergency department physicians have less of a problem finding substitutes for most controlled substance drugs, said Robert O’Connor, MD, a member of the board of the American College of Emergency Physicians. “If there’s a shortage of morphine, we can use something else to replace it. What has alarmed our members is where a particular drug is the only one in the class and there’s no real substitute for it.”
He cited etomidate, a sedation agent that is often used in emergency department procedures involving dislocated shoulders or fracture reductions. “There is no real substitute for it, and we’ve had to use less efficacious agents,” he said, adding that patients may suffer as a result. “You may not achieve the desired level of sedation when you’re putting somebody’s shoulder back in place because you don’t have the proper drug.”
The shortages of analgesics and sedatives also affect patients and physicians in ambulatory care, observed Lynn Webster, MD, past president of the American Academy of Pain Medicine.
“It compromises our ability to give the patients what they need,” he said. “You have to look for an alternative, and sometimes the alternative is not as effective and may also have side effects. It also takes a lot of time, and it adds to the level of frustration for physicians and patients.”
Moreover, he said, some shortages have led to patients not getting the medications they need. “We’ve seen a trend over the past 3 years of physicians not treating or trying to avoid treating patients with opioids. We’ve seen that with the up­scheduling of hydrocodone. It’s a hassle factor, and physicians are just throwing up their hands, and patients are the ones who suffer.”
Medscape Medical News © 2015  WebMD, LLC
Send comments and news tips to news@medscape.net.
Credit: GAO Report Claims DEA to Blame for Many Drug Shortages. Medscape. Mar 17, 2015.

Categories: News

Follow Us!

Visit Us On TwitterVisit Us On LinkedinVisit Us On FacebookVisit Us On YoutubeVisit Us On GooglePlus

Subscribe to our blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 18 other subscribers

icon

Videos

icon

Appointments

icon

New Patient Packet

icon

Travel/Location

Featured Posts

Trial Spinal Cord Stimulation

Spinal cord stimulation is a method of pain management that can help reduce chronic pain in many individuals. Often used as a means of treatment when it seems as though little else has or will work, this is often the measure of last resort that ends up makingRead More >

Conditions That Benefit From Peripheral Nerve Stimulation

causes of chronic pain

In addition to the general misunderstanding that often surrounds peripheral nerve stimulation as a form of pain management, there is also a lack of understanding about the types of conditions that this therapy can be used to treat. Chronic back pain is not the only condition that can benefit fromRead More >

Complex Regional Pain Syndrome Diagnosis and Treatment

Diagnosing and treating complex regional pain syndrome (CRPS) can be complicated, but with a team of pain specialists and experts, an accurate diagnosis and treatment plan can be achieved. The best way to diagnose this chronic condition is by ruling out other conditions, like rheumatoid arthritis, for example.Read More >

More Blog Posts

  • Spinal Cord Stimulator Technology Continues to Improve Patient Pain Relief Efforts
  • Controversial Survey Study Shows Increase in U.S. Adults Using ‘Stronger’ Opioids
  • 11 Tips for Living With Chronic Pain
  • Why Do People Abuse Pain Medication
  • Malignant Cells Lead Assault on Nerve Fibers, Drive Cancer Pain (3 part series)
  • ASAM Releases National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
  • How Spinal Cord Stimulation Works
  • How to Handle Severe Pain
  • Flowonix Medical Inc. Announces First Implants of Prometra® II
  • Head Injury Causing Chronic Pain?
  • Suicide and Pain: Research Explores Links to Suffering, Acceptance, Burden
  • When The Prescription Becomes The Problem
  • Top Causes of Chronic Pain
  • Pharmacist Survey Raises Concerns for Patient Access to Generic Pain Drugs
  • SCS vs CMM-A Controlled Trial
  • Complex Regional Pain Syndrome-Distract Yourself
  • Back Packs and Back Pain
  • Chronic Back Pain-an Overview
  • What is Diabetic Peripheral Neuropathy and How Can It Be Treated?
  • Back Pain & Spinal Injections
  • GAO Report Claims DEA to Blame for Many Drug Shortages
  • Cannabinoids – Time for a More Rational Cannabis Policy
  • Pain: Some Not So Fun Facts
  • Back Pain & Spinal Cord Stimulation Therapy
  • Nerve Damage-Basic Overview
  • Medical Marijuana Debate
  • Stress & Chronic Pain
  • Chronic Pain & Negative Emotions Tied Together
  • What is Diabetic Peripheral Neuropathy and How Can It Be Treated?
  •  What is Spinal Cord Stimulation?
  • Diabetic Peripheral Neuropathy & Treatments
  • VIDEO: DEA helped create prescription issues when it reclassified drugs
  • Stress Affects on Chronic Pain
  • WKMG-Pharmacies Deny Consumers Pain Prescriptions
  • OMG (Observational Mechanical Gateway) Success Stories
  • Why Emotional Pain Increases Physical Pain
  • Tips on Living With Chronic Pain
  • Living a Full Life With Chronic Pain
  • Causes of Chronic Pain
  • Traumatic Brain Injuries Contribute To Issues Elsewhere In The Body
  • Dealing With Chronic Pain Caused by Head Injuries
  • Pain: Tricking the Brain
  • Peripheral Field Nerve Stimulation
  • Weather and Chronic Pain
  • Understanding Spinal Cord Stimulation for Chronic Pain
  • Complex Regional Pain Syndrome Diagnosis and Treatment
  • Conditions That Benefit From Peripheral Nerve Stimulation
  • Trial Spinal Cord Stimulation

Pain Treatment Centers-2300 South Pine Ave, Ocala, FL 34471

(352) 861-4600